Saam Noroozi
Overview
Explore the profile of Saam Noroozi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tavan A, Noroozi S, Zamiri B, Gholchin Vafa R, Rahmani M, Mehdizadeh Parizi M, et al.
BMC Nutr
. 2022 Nov;
8(1):138.
PMID: 36434733
Background: Dyslipidemia is a prominent cause of cardiovascular disease as it leads to inflammation and plaque deposition within arteries. Treatment includes lifestyle modifications and lipid-lowering medications. We aimed to assess...
2.
Rostami A, Vakili S, Koohpeyma F, Jahromi B, Aghajari Z, Mahmoudikohani F, et al.
BMC Complement Med Ther
. 2022 Jun;
22(1):170.
PMID: 35739528
Background: Busulfan is an antineoplastic medication that is broadly utilized for cancer treatment. It affects the testicular function and leads to sterility. The present study aimed to evaluate the effects...
3.
Samangooei M, Farjam M, Etemadifar M, Taheri A, Meshkibaf M, Movahedi B, et al.
Sci Rep
. 2022 Feb;
12(1):2160.
PMID: 35140322
Multiple sclerosis is an inflammatory disease of the spinal cord and brain. Receptor for advanced glycation end products and Apolipoprotein A1 (Apo-AI) have been recommended to have a pathogenic role...
4.
Vakili S, Samare-Najaf M, Dehghanian A, Tajbakhsh A, Askari H, Tabrizi R, et al.
Nanoscale Res Lett
. 2021 Sep;
16(1):144.
PMID: 34529188
Brucellosis is considered as the most common bacterial zoonosis in the world. Although the laboratory findings are the most reliable diagnosis today, the current laboratory methods have many limitations. This...
5.
Samangooei M, Farjam M, Niknam Z, Etemadifar M, Meshkibaf M, Noroozi S
Metab Brain Dis
. 2021 Jun;
36(7):1929-1934.
PMID: 34115275
Matrix metalloproteinase, especially Matrix metalloproteinase-9 (MMP-9) has vital roles in the disruption of blood barrier, neuroinflammation and pathogenesis of multiple sclerosis (MS) patients. The goal of this study is to...
6.
Akbari H, Tabrizi R, Lankarani K, Aria H, Vakili S, Asadian F, et al.
Life Sci
. 2020 Aug;
258:118167.
PMID: 32735885
Aims: This study aimed to make a comparison between the clinical laboratory-related factors, complete blood count (CBC) indices, cytokines, and lymphocyte subsets in order to distinguish severe coronavirus disease 2019...
7.
Asadikaram G, Ebrahimi Meimand H, Noroozi S, Sanjari M, Zainodini N, Arababadi M
Biotechnol Appl Biochem
. 2020 Apr;
68(2):267-271.
PMID: 32311159
The aims of this study were to compare mRNA levels of melanoma differentiation-associated protein 5 (MDA5) and retinoic acid-inducible gene 1 (RIG-1) in multiple sclerosis (MS) patients in comparison to...
8.
Asadikaram G, Noroozi S, Ebrahimi Meimand H, Sanjari M, Zainodini N, Khoramdelazad H, et al.
Neuroimmunomodulation
. 2017 Apr;
23(5-6):345-351.
PMID: 28433998
Objectives: Interferon-β 1a (IFN-β 1a) is a common strategy therapy for multiple sclerosis (MS) with unknown mechanisms. S100A12 (S100 calcium-binding protein A12) is a damage-associated molecular pattern molecule which binds...
9.
Noroozi S, Ebrahimi Meimand H, Arababadi M, Nakhaee N, Asadikaram G
Mol Neurobiol
. 2016 Apr;
54(4):3031-3037.
PMID: 27032392
This study aims to evaluate the effects of treatment with IFN-β 1α on the expressions of NLRP3, NLRP1, NLRC4, and AIM2, as inflammasomes, and caspase-1, IL-1β, and IL-18, as the...